These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30745219)

  • 1. Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).
    Mangat AK; Schmölzer GM; Kraft WK
    Semin Fetal Neonatal Med; 2019 Apr; 24(2):133-141. PubMed ID: 30745219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
    Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
    JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of neonatal abstinence syndrome from opioids.
    Grim K; Harrison TE; Wilder RT
    Clin Perinatol; 2013 Sep; 40(3):509-24. PubMed ID: 23972754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies.
    Raffaeli G; Cavallaro G; Allegaert K; Wildschut ED; Fumagalli M; Agosti M; Tibboel D; Mosca F
    Pharmacotherapy; 2017 Jul; 37(7):814-823. PubMed ID: 28519244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid treatment for opioid withdrawal in newborn infants.
    Zankl A; Martin J; Davey JG; Osborn DA
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002059. PubMed ID: 34231914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
    Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
    J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Neonatal Abstinence Syndrome: An Overview.
    Wexelblatt SL; McAllister JM; Nathan AT; Hall ES
    Clin Pharmacol Ther; 2018 Jun; 103(6):979-981. PubMed ID: 29285767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
    Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
    J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
    MacMillan KDL
    Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
    Wachman EM; Schiff DM; Silverstein M
    JAMA; 2018 Apr; 319(13):1362-1374. PubMed ID: 29614184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
    Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G
    Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for the Treatment of Neonatal Abstinence Syndrome.
    Cook CE; Fantasia HC
    Nurs Womens Health; 2019 Aug; 23(4):357-365. PubMed ID: 31251931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
    Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Abstinence Syndrome Management: A Review of Recent Evidence.
    Grossman M; Seashore C; Holmes AV
    Rev Recent Clin Trials; 2017; 12(4):226-232. PubMed ID: 28814260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
    Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
    Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
    Kraft WK; Adeniyi-Jones SC; Chervoneva I; Greenspan JS; Abatemarco D; Kaltenbach K; Ehrlich ME
    N Engl J Med; 2017 Jun; 376(24):2341-2348. PubMed ID: 28468518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.